222 related articles for article (PubMed ID: 7533425)
1. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R
Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
[No Abstract] [Full Text] [Related]
2. Effect of recipient T cell subset depletion on graft coronary arteriosclerosis induction in the rat retransplant model.
Izutani H; Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Nakata S; Matsuda H
Transplant Proc; 1996 Jun; 28(3):1828-9. PubMed ID: 8658903
[No Abstract] [Full Text] [Related]
3. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
[No Abstract] [Full Text] [Related]
4. The role of histoincompatibility in cardiac allograft vasculopathy.
Costanzo MR
J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
[No Abstract] [Full Text] [Related]
5. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
Pan F; Valdivia LA; Tsugita M; Celli S; Haeuchi K; Demetris AJ; Avci G; Fung JJ
Transplant Proc; 1994 Jun; 26(3):1211. PubMed ID: 7518113
[No Abstract] [Full Text] [Related]
6. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease?
Hauptman PJ; Nakagawa T; Tanaka H; Libby P
J Heart Lung Transplant; 1995; 14(6 Pt 2):S173-80. PubMed ID: 8719481
[No Abstract] [Full Text] [Related]
7. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
[No Abstract] [Full Text] [Related]
8. Effects of interferon alpha/beta on cardiac allografts.
Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M
Transplant Proc; 1996 Jun; 28(3):1250-1. PubMed ID: 8658645
[No Abstract] [Full Text] [Related]
9. Inhibition of graft coronary arteriosclerosis after heart transplantation.
Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A
Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of smooth muscle and non-muscle myosin heavy chain isoforms in rejected hearts: a sensitive marker for acute rejection and graft coronary arteriosclerosis.
Suzuki J; Aikawa M; Isobe M; Sekiguchi M; Yazaki Y; Nagai R
Transplant Proc; 1995 Feb; 27(1):578. PubMed ID: 7879106
[No Abstract] [Full Text] [Related]
11. Lymphocytic subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis.
Cramer DV; Wu GD; Chapman FA; Cajulis E; Wang HK; Makowka L
J Heart Lung Transplant; 1992; 11(3 Pt 1):458-66. PubMed ID: 1610855
[TBL] [Abstract][Full Text] [Related]
12. Does endotoxin accelerate rejection in a cardiac allograft model?
Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL
Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903
[No Abstract] [Full Text] [Related]
13. Is donor-specific blood transfusion effective for strong minor histocompatibility antigen barriers?
Hara MH; Suzuki H; Shibata K; Tanigawa M; Sekiya R; Matsuzaki Y; Onitsuka T; Koga Y; Yamashita A; Miyamoto M; Suzuki S; Amemiya H; Kimura H
Transplant Proc; 1996 Jun; 28(3):1268-9. PubMed ID: 8658654
[No Abstract] [Full Text] [Related]
14. A new rat infection-heart transplant model: effect of infection on graft survival studies.
Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts.
Libby P; Tanaka H
Clin Transplant; 1994 Jun; 8(3 Pt 2):313-8. PubMed ID: 7520306
[TBL] [Abstract][Full Text] [Related]
16. Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease.
Takami H; Backer CL; Crawford SE; Pahl E; Mavroudis C
J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):67-77. PubMed ID: 8820085
[TBL] [Abstract][Full Text] [Related]
17. The importance of donor MHC compatibility in the allo- and autoimmune destruction of islet grafts in the BB rat.
Stegall MD; Chabot JA; Tezuka K; Reemtsma K; Hardy MA
Transplant Proc; 1990 Apr; 22(2):844. PubMed ID: 2109414
[No Abstract] [Full Text] [Related]
18. Induction of acute rejection by indirect recognition of donor MHC antigens.
Terness P; Dufter C; Otto G; Opelz G
Transplant Proc; 1995 Feb; 27(1):457-8. PubMed ID: 7879060
[No Abstract] [Full Text] [Related]
19. Microchimerism and graft acceptance: cardiac allografting with multiple minor histocompatibility antigen differences.
Hara MH; Shibata K; Matsuzaki Y; Onitsuka T; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Yamaguchi A; Iwaya M; Masaki Y; Kimura H
Transplant Proc; 1996 Jun; 28(3):1293-4. PubMed ID: 8658665
[No Abstract] [Full Text] [Related]
20. Does FK 506 accelerate the development of coronary artery disease in the transplanted heart as well as the native heart?
Shibata T; Ogawa N; Koyama I; Ksaneko N; Hokazono K; Omoto R
Transplant Proc; 1993 Feb; 25(1 Pt 2):1145-8. PubMed ID: 7680147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
